**Core Concept**
Levodopa is a precursor to dopamine, used in the treatment of Parkinson's disease. The combination of levodopa with other medications requires careful consideration to avoid adverse interactions.

**Why the Correct Answer is Right**
Levodopa is metabolized by catechol-O-methyltransferase (COMT) and aromatic L-amino acid decarboxylase (AADC). Carbidopa, a decarboxylase inhibitor, is often co-administered with levodopa to prevent its conversion to dopamine outside the brain. However, some medications can interfere with this pathway. **Option B**, Entacapone, is a COMT inhibitor, which can increase levodopa levels and reduce its efficacy. This is because COMT inhibition can lead to the accumulation of levodopa metabolites, increasing the risk of adverse effects.

**Why Each Wrong Option is Incorrect**
* **Option A:** Ropinirole is a dopamine agonist, which can be given along with levodopa to enhance its effects. In fact, combination therapy with levodopa and dopamine agonists is a common approach in Parkinson's disease management.
* **Option C:** Trihexyphenidyl is an anticholinergic medication, used to treat Parkinson's disease symptoms such as tremors. It can be given along with levodopa to manage these symptoms.

**Clinical Pearl / High-Yield Fact**
When combining medications with levodopa, it's essential to consider their effects on the COMT and AADC pathways to avoid adverse interactions.

**Correct Answer:** B. Entacapone.